The latest news, developments and research findings from all fields of science including biology, chemistry, physics, psychology, sociology and space, including news on the latest policies regulating this sector.
The Circular Bio-based Europe Joint Undertaking (CBE JU) has officially opened its 2025 call for project proposals, offering €172 million in funding to accelerate the development of sustainable, bio-based solutions across Europe.
Open Access Government discusses how the U.S. NSF’s Division of Astronomical Sciences continues to break boundaries in research and discovery, yet remains conscious of...
Open Access Government explores the work of the American Association for the Advancement of Science (AAAS), and how the organisation continues to ensure that all of society benefit from scientific innovation.
New data from the REACT study finds that the prevalence of COVID is down by 60% in one month, but primary school children have the highest COVID infection levels.
Scientists have developed an implantable sensor using gold nanoparticles, which can function in the human body for "several months" to report health changes.
Here, Open Access Government learns all about the initiatives of the Japan Society for the Promotion of Science to promote scientific excellence on both a national and global scale.
Open Access Government discusses the importance of funding visionaries, explorers and innovators who are searching for scientific and technical breakthroughs in Canada.
Researchers have discovered a deadly new snake species in Asia, which has been named Suzhen's krait after the mythical figure of Bai Su Zhen - a snake goddess who saved a lot of human lives.
Here, M. Danner & R. M. Winglee* describe the viability of microbial sampling within impact lander craters in extraplanetary ice, including the possibility of life beyond our planet.
Sherry A. Southerland and Jennifer Schellinger tell us what we need to know about Learning Through Collaborative Design-Professional Development (LCD PD) in this special science education focus.
We spoke with Dr Matthew Duchars, CEO of the UK’s first dedicated Vaccines Manufacturing and Innovation Centre (VMIC), about their work not only to provide an integral response to COVID-19, but as a centre of excellence advancing the vaccine sector on a global scale.
A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.
Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
